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Abstract 
Preparations of palytoxin (PLTX, derived from Japanese Palythoa tuberculosa) and the congeners 
42-OH-PLTX (from Hawaiian P. toxica) and ovatoxin-a (isolated from a Japanese strain of 
Ostreopsis ovata), as well as a 50:50 mixture of PLTX and 42-OH-PLTX derived from Hawaiian P. 
tuberculosa were characterized as to their concentration, composition, in-vitro potency and 
interaction with an anti-PLTX monoclonal antibody (mAb), after which they were evaluated for 
lethality and pathophysiological effects by intraperitoneal (IP) and aerosol administration to rats.  
Once each preparation was characterized as to its toxin composition by LC-HRMS and normalized to 
a total PLTX/OVTX concentration using HPLC-UV, all four preparations showed similar potency 
towards mouse erythrocytes in the erythrocyte hemolysis assay and interactions with the anti-PLTX 
mAb. The IP LD50 values derived from these experiments (1-3 µg/kg for all) were consistent with 
published values, although some differences from the published literature were seen.   The aerosol 
LD50 values (.03-.06 µg/kg) confirmed the exquisite potency of PLTX suggested by the 
literature. The pathophysiological effects of the different toxin preparations by IP and aerosol 
administration were similar, albeit with some differences.   Most commonly affected tissues were 
the lungs, liver, heart, kidneys, salivary glands, and adrenal glands. Despite some differences, 
these results suggest commonalities in potency and mechanism of action among these PLTX 
congeners.   
  
1. Introduction 
 
 Palytoxins (PLTXs) are a family of extremely potent marine toxins, considered to be 
among the most toxic non-proteinaceous substances known. The first member of this family, 
then called PLTX and now recognized as 42-OH-PLTX (see below), was isolated from the 
marine coelenterate zoanthid Palythoa toxica from a remote tidal pool in Hawaii (Moore and 
Scheuer, 1971). PLTX congeners have since been described from several additional Palythoa 
species and from dinoflagellates of the genus Ostreopsis (Uemura, et al, 1985; Beress, et al, 
1983, Oku, et al. 2004). Among the PLTX analogs described from Ostreopsis species are the 
mascarenotoxins A and B from Indian Ocean O. mascarenensis (Lenoir, et al 2004), ostreotoxins 
-1 and -3 from Caribbean O. lenticularis (Mercado, et al 1994), and multiple ovatoxins from 
Mediterranean O. ovata (Ciminiello, et al, 2008, 2012a, 2012b).  PLTXs are thus found in 
zooanthids and dinoflagellates distributed throughout tropical and sub-tropical habitats, as well 
as in temperate waters of the Mediterranean and Adriatic Seas. Further, they have been isolated 
from seafood (fish, crabs, invertebrates) linked to human illnesses and death, and marine aerosols 
linked to numerous cases of flu-like symptoms, ocular irritation, and respiratory distress. Finally, 
PLTXs have been found in high concentrations in marine zooanthids commonly distributed in 
the home and commercial aquarium trade.  Here they have been associated with severe 
respiratory reactions and corneal damage due to inadvertent contact and the presumed production 
of aerosols during tank maintenance and cleaning (Deeds, 2014).  
The natural production of PLTXs by different organisms demonstrates a certain degree of 
biological variability.  The original structural determination of palytoxin was reported 
independently by two groups (Moore and Bartolini, 1981; Uemura, et al. 1981), and slight 
differences in structure and molecular weight were reported for preparations obtained from a 
Tahitian species of Palythoa, Hawaiian P. toxica, and Japanese P. tuberculosa. PLTX and 
ovatoxin congeners are minor variations on a common backbone structure (Figure 1, Table 1).   
Retrospectively, it would appear that the toxin preparations of these two groups may have 
contained different congeners in different ratios.  Our preparation of PLTX from Hawaiian P. 
toxica, originally believed to be pure palytoxin, has since been demonstrated to be almost 
entirely (>90%) composed of the 42-OH derivative, while another preparation from Hawaiian P. 
tuberculosa, produced concurrently and also originally believed to be pure palytoxin, is now 
known to be a 50:50 mixture of PLTX and 42-OH PLTX (Ciminiello, et al, 2010).  Strains of 
wild Ostreopsis ovata in the northern Adriatic (Accoroni, et al 2011) and cultured O. ovata from 
Brazil (Nascimento et al 2012) have shown ovatoxins-a and –b dominating the toxin profiles, 
with PLTX present in only trace amounts.  Strains of Ostreopsis siamensis from Japan produce 
ostreocin-D, a less potent congener (Ito and Yasumoto, 2009).  In all cases, trace amounts of 
other congeners (i.e. ovatoxins c-k) are nearly always present.  Although congeners can be 
separated using advanced analytical techniques, isolation of pure toxins in high yield is 
extremely challenging.  For this reason, complete structural assignments for all known ovatoxin 
congeners are not yet possible.  
 In 1964, using the original semi-purified toxin preparations from Hawaiian Palythoa 
toxica, (based on current knowledge most likely 42-OH PLTX but possibly a mixture of PLTX 
and 42-OH PLTX) monkeys, dogs, rabbits, guinea pigs, rats, and mice were evaluated by various 
routes of exposure (Wiles, Vick, and Christiensen, 1974). The most potent route was found to be 
intravenous, with 24 hr LD50 values ranging from 0.025-0.45 µg/kg depending upon the species 
tested.  LD50 values of 0.24-0.63 µg/kg were observed by the intramuscular, subcutaneous, 
intraperitoneal and intratracheal routes.  Oral and intrarectal routes of exposure were much less 
toxic.  Ito and Yasumoto (2009) confirmed the lower oral toxicity for PLTX and ostreocin-D, but 
observed bleeding and alveolar destruction in the lungs, gastrointestinal erosion, atrophy in the 
renal glomeruli, and death within 2 hrs in mice administered 2 μg/kg PLTX and 11 μg/kg 
ostreocin-D by the intratracheal route.   
 
 
 
 
Figure 1.  Basic backbone structures of PLTX and the major congeners. (From Pelin, et al., 
2016) 
 
 
Table 1.  Structural modifications of the PLTX backbone comprising the ovatoxins. (From 
Ciminiello, et al, 2014) 
 
 PLTXs are atypical of most known marine toxins in that they pose risks to humans 
through multiple routes of exposure (oral, inhalational, and dermal) and multiple vectors 
(planktivorous and carnivorous fish, crustaceans, shellfish, and waters containing Ostreopsis 
cells or zoanthids) (Deeds and Schwartz, 2010). Tubaro et al. (2011) reviewed a series of case 
reports and anecdotal references describing the adverse effects on human health for different 
routes of exposure and proposed case definitions for PLTX poisoning. Some of the least studied 
suspected PLTX exposures involve adverse reactions in humans due to dermal, ocular, and 
inhalational exposures in persons in close proximity to waters containing blooms of Ostreopsis 
(i.e. swimmers, divers, fisherman), as well as in marine aquarium hobbyists and maintenance 
workers exposed to toxic zoanthids.  
 Of particular interest are the observations of acute toxicity following aerosol exposures.  
One noteworthy example occurred in 2005 when ~ 200 beach-goers experienced symptoms of 
rhinorrhea, cough, mild dyspnea, bronchoconstriction, and fever that coincided with a bloom of 
Ostreopsis ovata along the Mediterranean coast near Genoa, Italy (Ciminiello, et al, 2006). Some 
people also experienced conjunctivitis and 20 individuals required extended hospitalization. 
Altogether, hundreds of cases fitting the description of “Algal Syndrome” have now been 
reported throughout the northern Mediterranean and Adriatic seas in association with exposure to 
waters containing Ostreopsis ovata  (Durando, et al, 2007). The concentrations of PLTX and/or 
PLTX-like compounds required to cause these effects are still unknown. These incidents, and 
many others like them, suggest that PLTXs are a family of toxins that pose a significant risk to 
humans through aerosol exposure.  
 The purpose of this study was to characterize four different preparations of PLTX and 
congeners as to content and purity.  Further, we aimed to compare toxicity and basic 
histopathological effects of each preparation after intraperitoneal (IP) and aerosol administration 
to rats to better understand differences between congeners.  This work is preliminary and 
supportive of aerosol toxicology studies in nonhuman primates, which will be reported 
separately.  Ultimately, we will develop an animal model for aerosol toxicology of PLTX 
exposure to be used for testing and evaluation of medical countermeasures. 
 
2. Materials and Methods 
 
2.1 Toxin preparations 
 Preparation 1, a 50:50 mixture of PLTX/42-OH PLTX, and Preparation 2, containing 
>90% 42-OH PLTX, were purified previously from Hawaiian P. tuberculosa and P. toxica, 
respectively, by the Hawaii Biotechnology Group under contract to the US Army Medical 
Research Institute of Infectious Diseases (USAMRIID) as reported by Bignami, et al (1992).  
Preparation 2 was prepared from P. toxica obtained from the original tide pool near Hana, on the 
island of Maui, described by Helfrich (Moore and Scheuer, 1971). Preparation 3 was a 
commercially available preparation of PLTX (~90-95% pure) purchased from Wako Pure 
Chemical Industries, Osaka, Japan. Preparation 4 was a mixed ovatoxin preparation containing 
primarily ovatoxin–a purified from a Japanese strain of Ostreopsis ovata (see below). 
 
2.2 Ostreopsis ovata culture and purification of ovatoxins 
 
2.2.1 General culture methods 
 
The toxic Ostreopsis ovata, strain NIES-3351, was obtained from the National Institute of 
Environmental Studies, Tsukuba, Japan and was maintained in modified f/2-Si medium (Guillard 
and Ryther, 1962) as modified by Anderson et al., (1994).  The medium was prepared using 
autoclaved 0.2 µm filtered, UV-irradiated, Vineyard Sound, MA seawater (salinity ~ 32 ppt) for 
cultures up to 1L which were grown in 2.8L Fernbach flasks.  Larger, 17L cultures were grown 
in sterilized glass carboys filled with sterile nutrient-enriched filtered seawater prior to 
inoculation with 1L of exponentially growing culture.  During incubation, carboys were bubbled 
with filter- sterilized air supplied by an aquarium pump. 
 
All cultures were maintained at 23 C on a 14:10 h light:dark cycle (ca. 250 µmol 
photonsꞏm-2ꞏsec-1 irradiance provided by cool white fluorescent bulbs). Cultures were incubated 
for ~30 days prior to harvest to maximize cellular toxin production (Pezzolesi et al, 2014). 
 
For culture harvest, the contents of individual or multiple Fernbach flasks were added to a 
tightly capped, pre-weighed vessel that was at least 1L larger in volume than the total culture 
harvest volume.  The culture was vigorously agitated to free individual cells from the mucous 
webs that are characteristic of Ostreopsis cultures.  Clumps of cells varied in size, ranging from 
10s to 100s of cells. Without delay, triplicate 1.5 mL aliquot of the dispersed culture were 
collected and preserved with ~30µL Utermohls solution.  A minimum of 400 cells were counted 
using a microscope at 100X total magnification in a Sedgewick-Rafter chamber.  Following this, 
the collection bottle was weighed and this weight, less the empty bottle weight, divided by the 
density of seawater (1.03g/mL) provided the volume of culture harvested.  On average, 
approximately 7 x 106 cells were contained in each of the harvested 1L volumes of culture. After 
collection of the cell counts, the culture was filtered through a 13µm Nitex sieve to concentrate 
the cells.  Using the filtrate, the cell concentrate was backwashed into a 50mL disposable 
centrifuge tube which was spun @ 3000 x g for 15 minutes.  The overlying seawater was then 
removed by aspiration.  When multiple flasks or carboy volumes of the culture were harvested, 
the contents were passed through a small (20 cm dia. x 60 cm L) 10-µm plankton net and the 
collected cells rinsed into 250mL disposable centrifuge bottles and processed as above.  The 
resulting cell pellet was transferred to 50mL disposable centrifuge tubes and using the same 
methods as before, concentrated using centrifugation until all the biomass was collected in a 
single 50mL tube.   It was not possible to collect reliable cell count samples from carboy cultures 
but it is assumed that the cell densities were similar to those quantified in the 1L cultures.  All 
samples were stored at -80 C following harvest and were shipped on dry ice prior to extraction. 
 
 
 
2.2.2 Extraction and purification of ovatoxins 
 
 Ten cell pellets, each representing 1 L of culture, were extracted individually with 10 ml of 
50:50:0.1 methanol/water/acetic acid following Ciminiello et al. (2012) and Ukena et al. (2001).  
Each pellet was extracted twice (10 ml each) by sonicating for 1 minute, using a probe sonicator 
on ice, followed by centrifugation.  The extracts were combined (ca. 200 ml total), placed in a 1L 
glass separatory funnel, and extracted 5 times with 300 ml each of dichloromethane.  The 
remaining de-fatted extract was taken to dryness under vacuum using a rotary evaporator at 30°C 
to remove any residual dichloromethane.  The residue was re-dissolved in 50 ml of extraction 
solvent and dried again in a rotary evaporator stopping with approx. 5 ml remaining.  This final 
extract was diluted with 20 ml of 50:50 methanol/water and stored at -20°C.  At this point the 
extract was a milky pale yellow color.  To clear the solution further for HPLC analysis and 
fractionation, 10,000 MW spin filters (Amicon® Ultra-15, part# UFC901024, Millipore, Ltd. 
Carrigtwohill, Ireland) were used, resulting in a clear pale-yellow solution.  HPLC analysis with 
UV detection, following Deeds et al. (2011), of the clear solution revealed that the 
chromatograms were significantly cleaner after this purification step. For further purification, 
repeated 200 µl injections were run over a Gemini C18 column (5 µm, 110 Å, 150 mm × 2 mm) 
(Phenomenex, Torrance, CA), with fraction collection, using an Agilent 1200 series HPLC 
system (Agilent, Wilmington, DE) equipped with an extended injection kit (Part# G1363-68700) 
and a 1260 Infinity Series fraction collector (Part# G1364C). Samples was eluted using a 
gradient of 20% solvent A/80% solvent B to 100% solvent A over 10 min at 250 ml/min., 
followed by a 5 min hold at 100% solvent A at 30 °C [Solvent A: 95% acetonitrile in HPLC 
grade water/30 mM acetic acid, Solvent B: HPLC grade water/30 mM acetic acid]. Starting 
gradient conditions were maintained for 5 min. post injection and 10 min. post gradient elution. 
PLTX/OVTX-like compounds were determined by their characteristic UV absorbances at 233 
and 263 nm. As shown by Ciminiello et al. (2015), this column and elution conditions results in a 
single combined PLTX/OVTX peak. The OVTX containing peaks were collected, pooled, and 
re-chromatographed to check purity.  The OVTX preparation was finally concentrated under a 
stream on N2 at 40°C, adjusted to a concentration of 300 µg/ml with 50:50 methanol/water and 
quantified using the scheme described below.   
 
2.2.3 Quantification and Characterization of PLTX/OVTX preparations  
 
Toxin preparations were quantified via HPLC with UV detection at 263 nm. Linear 
regressions were performed in 50;50 methanol/water against a PLTX standard of  P. tuberculosa 
purchased from Wako Pure Chemical Industries, Japan. Although not a certified reference 
standard, this standard t is the best characterized commercial preparation available and has been 
used by others in similar work. Linear regression analysis was performed using GraphPad Prism 
software (ver. 4.03, GraphPad Prism Software, Inc., San Diego, CA). This method provided a 
combined concentration of PLTX/OVTX for Preparation 1, 2, and 4. The concentration of 
Preparation 3, PLTX from P. tuberculosa from Wako Pure Chemical Industries, was assumed to 
be correct. 
The four toxin preparations were confirmed as to their identity by liquid chromatography- 
high resolution mass spectrometry (LC-HRMS) using an Agilent 1290 Infinity UPLC coupled to 
an Agilent 6538 high resolution qTOF mass spectrometer operating in MS1 mode. Toxins were 
separated with an Agilent Poroshell 120 EC-C18 column (2.1 x 100 mm, 2.7 um) and a gradient 
of 28-29 %B over 15 min. at a flow rate of 0.3 mL/min. with mobile phases A = 30 mM acetic 
acid in water and B = 30 mM acetic acid in acetonitrile, following Ciminiello, et al. (2015). The 
qTOF recorded all ions eluting from the column and the resultant total ion chromatogram (TIC) 
was interrogated for ions related to PLTX/OVTXs. .  
 
2.3 In-vitro toxin preparation characterization and cross-reactivity with an anti-PLTX antibody. 
 
2.3.1 Preparation of 73D3 monoclonal antibody (mAb).  
 The 73D3 mAb producing hybridoma was produced previously by the Hawaii Biotechnology 
Group under contract to USAMRIID, as described in Bignami, et al. (1992).  Hybridoma culture 
supernatant was diluted 1:10 with 50 mM phosphate buffered saline (PBS) containing 0.02% 
Tween 20 (PBS/Tween) and circulated over a Protein A/G column (Sigma Chemical Co., St. 
Louis, MO) at 1 mL/min for the equivalent of 3 sample volumes.  After flushing the unbound 
material off the column with PBS/Tween, the column was eluted with 5 M glycine, pH 3.  The 
IgG peak was collected into an equal volume of 10× PBS, and then dialyzed for at least 16 hr 
against 5L of distilled water, with 3-4 buffer changes.  The dialyzed sample was then lyophilized 
and stored at room temperature in sealed glass ampules.  Prior to use, the lyophilized material 
was reconstituted with 50mM PBS at 1 mg/mL. 
2.3.2 Hemolysis neutralization assay 
 To compare the in-vitro potency of the four toxin preparations, each preparation was first 
quantified against the PLTX standard from Wako Pure Chemical Industries, Japan (from P. 
tuberculosa), as described above, and prepared as 10 µg/mL stocks in 50:50 methanol/water. 
Comparative in-vitro potency was assessed by hemolysis of mouse red blood cells (RBCs) both 
with and without the addition of the 73D3 mAb, similar to Bignami (1993). Brieﬂy, whole blood 
was drawn from strain CD1 female mice using 1.2 mL heparin coated blood collection tubes (S-
Monovette®, 1.2ml LH, Sarstedt, Nümbrecht, Germany) following an approved USAMRIID 
animal care and use protocol. Whole blood was washed three times with ice cold Tris buffer (150 
mM NaCl, 3.2 mM KCl, 1.25 mM MgSO4, and 2.2 mM Tris base, adjusted to pH 7.4 and then 
0.22 µm filter sterilized) by suspending in 5 volumes of Tris buffer followed by gentle mixing 
and centrifugation at 800×g for 5 min., with aspiration of the supernatant. For storage, the final 
RBC pellet was suspended in two times the original volume using Tris buffer plus 3.75 mM 
CaCl2.  For the assay, the mouse RBC suspension was diluted 10-fold in Tris buffer plus 1 mM 
CaCl2 and 0.5 mM H3BO4, for an RBC concentration of 5% of original.  To begin the assay, 100 
µL of toxin preparation, serially diluted in Tris buffer plus 1 mM CaCl2 and 0.5 mM H3BO4, was 
mixed in triplicate with either 100 µL of the 5% washed mouse RBC suspension, or the same 
RBC suspension pre-incubated for 30 min with 25 µg/mL 73D3 mAb, for a final RBC 
concentration of 2.5% of original. Samples (200 µL total) were mixed in 96 well V-bottom 
plates, sealed, and incubated for 4 h at 37 °C, after which time plates were centrifuged at 800×g, 
and 100 µL of supernatant from each well was transferred to a new ﬂat bottom 96 well plate. 
Absorbance of released hemoglobin was measured at 540 nm using a 96 well plate reader and % 
hemolysis was calculated through comparison to wells lysed with 10 µg saponin (from Quillaja 
bark; Sigma Chemical Co., St. Louis, MO). 
 
2.4 Animal studies 
 
2.4.1 Animals 
 Female Fischer F344 rats were purchased from Charles River Breeding Labs, Frederick MD, 
and were 5-7 weeks of age at the time of exposure. Animals were housed according to their 
experimental group and acclimated to their cage mates for at least 7 days prior to initiation of the 
study.  Prior to challenge, rats were implanted subcutaneously with Electric ID Transponder-
IPTT 300 (Bio Medic Data Systems, Seaford, Delaware) to measure body temperature and ID. 
Daily weights were determined on an Adventurer Pro Balance (Ohaus, Parsippany, New Jersey). 
2.4.2 Intraperitoneal exposures 
 Animal research at the United States Army Medical Research Institute of Infectious Diseases 
(USAMRIID) is conducted under an animal use protocol approved by the USAMRIID 
Institutional Animal Care and Use Committee in compliance with the Animal Welfare Act, 
Public Health Service policy, and other Federal statutes and regulations relating to animals and 
experiments involving animals.  The facility where this research was conducted is accredited by 
the Association for Assessment and Accreditation of Laboratory Animal Care International 
(AAALACi) and adheres to principles stated in the Guide to the Care and Use of Laboratory 
Animals (National Research Council, 2011). 
 Animals were divided into groups of 8 rats and challenged by IP injection on day 0.  The 
challenge doses were 0.25, 0.5, 1.0, 2.5, and 5.0 µg/kg.  Each IP dose was delivered in 100 µL of 
sterile phosphate buffered saline (PBS), after which the animals were monitored for clinical signs 
and symptoms twice daily for 7 days. Early intervention endpoints were employed during all 
studies and rats were humanely euthanized when moribund, according to an endpoint score 
sheet.  Animals were scored on a scale of 0 – 8, with 0-4 being absence of significant clinical 
signs (e.g. minor changes in fur and movement, stretching of hind limbs, subdued but normal 
when stimulated), and 5-7 being significant clinical symptoms (ruffled fur, ocular discharge, 
increased respiration, decreased mobility, subdued even when stimulated). A score of 8 
represented moribund animals (greatly labored respiration, gasping, inability to stand, and 
unresponsive when stimulated).  Animals receiving a score of 8 were humanely euthanized via 
CO2 exposure followed by bilateral thoracotomy. LD50’s were estimated by probit regression, 
with 95% confidence intervals estimated by delta method approximations in SAS proc 
NLMIXED SAS version 9.4. 
2.4.3 Aerosol exposures 
 The nose-only exposure was performed by using Automated Bioaerosol Exposure System 
(ABES II) system. Prior to rat exposures sham aerosols were performed with PLTX/42-OH 
PLTX from Hawaiian P. tuberculosa or 42-OH PLTX from P. toxica. The Collison Nebulizer 
was filled with a 10 mL solution of PLTX/42-OH or 42-OH PLTX, in a vehicle of 1 mg/mL rat 
albumin and 0.01%acetic acid in 50 mM phosphate buffered saline (PBS). A single all glass 
impinger (AGI) was prepared with 20 mL PBS and connected to the plenum for each of the sham 
tests. Each sham test was 15 minutes in duration followed by a five minute wash cycle. The AGI 
sample was analyzed to determine the aerosol concentration.  
 Animal inhalation exposures were performed for both dose response and serial sampling 
studies. For the first and second dose response exposures, Collison Nebulizer concentrations 
were 40, 8, and 4 µg/mL and 20, 4, 0.8, and 0.16 µg/mL PLTX/42-OH PLTX , respectively. 
Using the results from these exposures, we optimized the doses for the remaining studies at 8, 6, 
4, 2, and 0.8 µg/mL. All test article nebulizer preparations were solubilized in 10 mL PBS, rat 
albumin, and 0.1% acetic acid. Groups of eight Fisher 344 rats were loaded into the restraint 
tubes, passed into the BSC, and attached to the plenum. Dose response inhalation exposures were 
15-20 minutes in duration followed by a five minute wash cycle. Following the wash cycle, the 
rats were removed from the plenum and restraint tubes and transported back to their housing 
room. The AGI samples were collected and stored on ice until they could be assayed. A 
continuous APS sample was collected for each dose response exposure and analyzed to 
determine the PSD of the aerosols. 
 Two groups of 10 Fisher 344 rats were used for each serial sampling study. The Collison 
Nebulizer concentration was 4 µg/mL for each group.  
  Inhaled dose was calculated as the product of the aerosol concentration at the breathing 
zone of the rats on the plenum, minute volume, and exposure duration. Minute volume was 
estimated using the mean weight of all rats on the day of exposure and Guyton’s Equation (1). 
Aerosol concentration is normally calculated from the measured concentration in the AGI 
samples. However, due to the extreme potency of these toxins, and the dilution factors inherent 
to AGI sample collection, we were unable to directly measure our AGI samples and therefore 
accurately calculate the exposure doses. Therefore all doses were extrapolated based upon a 
higher measured dose and therefore estimates. Necessarily, these estimates do not account for 
run-to-run variation. However, the nose-only inhalation exposure system exhibits excellent 
linearity and stability and theoretical estimates of concentration closely matched the observed 
APS particle counts.         
 The particle size distributions (PSD) of the aerosolized toxins were determined using an 
APS fitted with an Aerosol Diluter. The mean Mass Median Aerodynamic Diameter and the 
mean Geometric Standard Deviation (MMAD, GSD) for sham exposures performed with 
PLTX/42-OH PLTX and 42-OH PLTX were 1.66 µm, 1.73 and 1.08 µm, 2.13, respectively.  
The mean Mass Median Aerodynamic Diameters and the mean Geometric Standard Deviations 
(MMAD, GSD) for animal exposures with PLTX/42-OH PLTX, 42-OH PLTX,  PLTX, and 
extracts of toxic O. ovata culture  were 1.05 ± 0.03 µm (n = 9), 2.50 ± 0.20 (n = 9), 1.04 ±0.01 
µm (n = 6), 2.12 ± 0.09 (n = 6), 1.11 ± 0.04 µm (n = 6), 2.07 ± 0.28 (n = 6) , and 1.05 ± 0.01 µm 
(n = 6), 2.22 ± 0.29 (n = 6), respectively.   
 Following the first sham exposure, rat albumin plus 0.1% acetic acid was added to the 
PBS vehicle to suppress the affinity of PLTXs for glass. This necessarily made the aerosol 
stickier. Although the test article aerosols were dried and mixed in transit, there was a large 
particle fraction evident in all PSDs. However, the mass fraction of particles greater than 3.5 µm 
was insignificant (less than 10%). For all exposures aerosols, at least 87.4% of the particle counts 
were less than 1.04 µm and at least 99.98% of the particle counts were less than 3.52 µm.  
   
2.4.4 Histopathology 
 Tissues were collected as soon as possible after death or euthanasia and placed in 10% 
neutral buffered formalin for a minimum of two days, after which they were submitted for 
histology. Each sample was trimmed, routinely processed, and embedded in paraffin. Sections of 
the paraffin-embedded tissues were cut 5 µm thick for histology.  Histology slides were de-
paraffinized, stained with hematoxylin and eosin (H&E), cover-slipped, and labeled.  The study 
pathologist (CS) reviewed the H&E stained slides of the following tissues: nasal cavity; eyes; 
ears (middle and inner); pituitary gland, brain (cerebrum and cerebellum); lungs; esophagus; 
trachea; thymus; lymph nodes (tracheobronchial, mediastinal, mandibular, axillary, inguinal, 
and/or mesenteric); heart; thyroid gland; liver; spleen; pancreas; stomach; duodenum; jejunum; 
ileum; cecum/colon/rectum/; right and left kidneys; adrenal glands; ovaries; uterus; urinary 
bladder; salivary glands; haired skin; femur and/or tibia; skeletal muscle of the hind limb.   
 
3. Results and Discussion 
 
3.1 Characterization of toxin preparations 
 
All four toxin preparations; Preparation 1: a 50/50 mixture of PLTX/42-OH PLTX from 
Hawaiian P. tuberculosa, Preparation 2, 42-OH PLTX from Hawaiian P. toxica, Preparation 3: 
PLTX from P. tuberculosa purchased from Wako Pure Chemical Industries, Japan, and 
Preparation 4: a mixed OVTX preparation containing primarily ovatoxin–a purified from a 
Japanese strain of O. ovata, were all confirmed as to their identity by LC-HRMS (Figure 2), 
quantified as to their total PLTX/OVTX concentration by HPLC-UV, and characterized as to 
their in-vitro potency and interaction with the 73D3 mAb through hemolysis neutralization assay 
(Figure 3).  
By LC-HRMS, using the most abundant ion in the spectrum, Preparation 1 was confirmed to 
be composed of roughly equivalent proportions of PLTX and 42-OH PLTX (observed m/z 
906.82 for the [M+H+Ca]3+ ion for PLTX and m/z 912.15 for the [M+H+Ca]3+ ion for 42-OH 
PLTX), Preparation 2 was confirmed to be composed of 42-OH PLTX (observed m/z 912.15 for 
the [M+H+Ca]3+ ion), Preparation 3 was confirmed to be composed of PLTX (m/z 906.82 for the 
[M+H+Ca]3+ ion), with a second later eluting less abundant peak with the same mass spectra 
suggesting that this peak is an isomer of PLTX, and Preparation 4 which was confirmed to be 
composed of OVTX-a (observed m/z 896.16 for the [M+H+Ca]3+ ion) with lesser amounts of 
two chromatographically distinct isomeric compounds with observed m/z 901.49, for both, 
identified as [M+H+Ca]3+ for OVTX-d and OVTX-e, according to Ciminiello, et al. (2015). It 
should be noted that the O. ovata strain used in this study (NIES-3351 from Japan) was reported 
previously to produce OVTXs that were identical in molecular weight but distinct in their 
chromatographic retention times compared to their corresponding OVTX congeners from Italian 
strains of O. ovata (Suzuki et al. 2012).  The authors termed these isomers “AC”, or Adachi 
Culture, derivatives. Since no standards are currently available for the OVTXs, we could not 
confirm that we produced the AC derivatives of OVTX-a, d, and e, but we assume this to be the 
case.  Previous work using this isolate (identified as strain s-0752 in Suzuki et al. (2012)) found 
it to produce primarily OVTX-a AC (ca. 85%) with the remainder being roughly equivalent 
amounts of OVTX-d AC and e AC, with trace amounts of PLTX and OVTX-b AC. With the 
exception of detecting trace amounts PLTX and OVTX-b AC, this is the same relative toxin 
composition found in our OVTX preparations. OVTX-a is the 42 hydroxy-17,44,64-trideoxy 
derivative of palytoxin (Figure 1). OVTX-a AC is reported to be a dideoxy-42-hydroxy-44-
deoxy derivative of palytoxin with the 2-unresolved hydroxyl loses occurring between C16 and 
C20 and C53 and C73, respectively, similar to OVTX-a (Suzuki et al. 2012).  This proposed 
structure has yet to be confirmed through structural elucidation by NMR. The potencies of the 
Japanese OVTX-AC derivatives compared to their corresponding Italian OVTXs have not been 
reported.  
 
Figure 2. LC-HRMS characterization of toxin preparations used for in-vitro and in-vivo potency 
assessments. A. 50:50 mixture of palytoxin and 42-OH palytoxin from Hawaiian P. tuberculosa. 
B.  42-OH palytoxin from Hawaiian P. toxica. C. Palytoxin from P. tuberculosa (purchased from 
Wako Pure Chemical Industries, Japan). “†” indicates second peak with same mass spectra as 
first PLTX peak, suggesting the presence of a PLTX isomer.  D. Ovatoxin prep from O. ovata 
isolate NIES-3351 from Japan. “‡” indicates singly charged contaminant peak that appears to 
be unrelated to OVTXs. For all: m/z values given were for the most abundant ion observed in the 
TIC spectra, and inset figure in each panel represents HPLC chromatogram with UV detection 
at 263 nm used for toxin quantification. 
 
 In-vitro potency and comparative interaction with the 73D3 mAb were assessed for the 
four toxin preparations through the use of a hemolysis neutralization assay. This assay is based 
upon the potent hemolytic activity of PLTXs towards erythrocytes.  The specificity of the 
activity is confirmed by neutralization by the PLTX-specific mAb. With total PLTX/OVTX 
concentrations normalized using HPLC-UV, the four toxin preparations showed very similar 
potency against the mouse RBCs with only the OVTX prep (Preparation 4) showing slightly 
lower hemolysis across all concentrations (Figure 3).  All four toxin preparations were 
neutralized to similar extents by the 73D3 mAb with hemolytic activity shifted two orders of 
magnitude at the 50% hemolysis level (Figure 3).   The ED50 doses for hemolysis were 
calculated to be 0.46, 0.37, 0.43, and 0.56 ng/mL for Preparations 1-4, respectively. These 
potency results are in contrast to those reported by Pelin et al. (2016), who reported a 10-fold 
difference in potency between ovatoxin-a and PLTX in a similar assay.  However, Pelin, et al. 
(2016) used OVTX-a from Italian strains of O. ovata, while we are assuming to have used the 
OVTX-a AC derivative. In addition, human erythrocytes were used in the Pelin et al. (2016) 
study, while we used mouse erythrocytes.  These two factors, either alone or in combination, 
could explain these conflicting results. 
 
Figure 3. Comparative hemolytic activity against mouse erythrocytes both with and without pre-
incubation with 25 µg/mL 73D3 mAb for the four toxin preparations. Prep 1: 50:50 mixture of 
palytoxin (PLTX) and 42-OH palytoxin (42-OH PLTX) from Hawaiian P. tuberculosa. Prep 2: 
42-OH PLTX from Hawaiian P. toxica. Prep 3: PLTX from P. tuberculosa (from Wako Pure 
Chemical Industries), Prep 4: ovatoxins (OVTXs) from O. ovata strain NIES-3351 from Japan. 
Symbols are average of triplicate wells, bars represent 1 SD (in most cases bars are smaller than 
the size of the symbol. 
 
3.2 Intraperitoneal administration studies 
 
3.2.1 Lethality 
The LD50 values calculated from the IP exposures for the four toxin preparations used in 
this study ranged from 0.92-3.26 µg/kg (Table 2).  This data confirms the high potency described 
in the literature, but differs from other published information in significant ways.  Ciminiello et 
al (2010) demonstrated that the 42-OH PLTX isolated from P. toxica used in this study was 
equipotent with  PLTX from Japanese P. tuberculosa (from Wako Pure Chemical Industries) in 
its ability to stimulate Ca++ influx in mouse skeletal muscle cells and in its ability to compete for 
[H3]-ouabain on purified porcine Na+/K+ ATPase.  Tubaro, et al (2011b) also demonstrated 
equipotency between these preparations in acute oral toxicity studies in mice.  However, 
Ciminiello, et al. (2014) determined that the 42-OH PLTX from P. tuberculosa (42S-hydroxy-
50R-palytoxin), Preparation 2 in this study, is a stereoisomer of that found in P. toxica (42S-
hydroxy-50S-palytoxin), contained in our Preparation 1, and had significantly lower potency 
toward skin HaCaT keratinocytes. This would suggest that Preparation 1 in our study (the 50:50 
mix from P. tuberculosa) should be less potent than Preparations 2 or 4 (42-OH-PLTX from P. 
toxica or the commercially-available PLTX from P. tuberculosa).  In fact, differences in potency 
in our study were minimal, as there was significant overlap in the 95% confidence intervals in 
our LD50 determinations in rats, and similar hemolytic potencies towards mouse erythrocytes and 
interaction with the 73D3 mAb.  In addition, Pelin, et al (2016) demonstrated that OVTX-a 
isolated from Mediterranean strains of O. ovata had a lower affinity for HaCaT cells, and a 
corresponding 100-fold lower potency than PLTX in reducing cell viability in the MTT test. 
While this in vitro data suggests that our OVTX-a preparation should be 10-100x less potent than 
the other preparations, our in vitro and in vivo data showed minimal differences in both 
hemolytic activity and lethal potency.  One possible explanation for this is that Japanese strains 
of O. ovata, have been reported by Suzuki et al (2012) to produce AC isomers of ovatoxins 
(explained above).  Toxicity comparisons of the AC analogs to the ovatoxins found in the 
Mediterranean and Adriatic have not yet been made, but it is conceivable that these proposed 
structural differences could affect potency.  Another possibility is that differences may arise from 
differences between in vivo and in vitro models used in the various studies.   
 Other published data in IP exposure to rats is scarce. Our LD50 results differed from than 
that of Wiles, et al (1974), who reported an IP LD50 in rats of 0.63 µg/kg.  However, there were 
several notable differences between our studies.  First, they used a crude toxin preparation from 
P. vestitus (later determined to be P. toxica) which was uncharacterized as to both toxin 
congeners and contamination, and they reported a significantly higher molecular weight (~3300).  
In addition, they used male rats weighing 200-250 g, while we used female rats weighing 
approximately 100 g. Whether experimental factors such as these can explain the differences in 
our results is unknown at this time.   
 
 
Toxin Prep                            Source                                                     LD50 (ug/kg) 
 
50:50 mix   Hawaiian P. tuberculosa    0.92 (0.54 – 1.54) 
42-OH-PLTX  Hawaiian P. toxica      1.93 (1.07 – 4.65) 
PLTX   Japanese P. tuberculosa   1.81 (1.11 – 3.30) 
Ovatoxin-a  Ostreopsis ovata culture   3.26 (2.04 – 5.66) 
 
Table 2.  Calculated LD50 values of different palytoxin preparations after intraperitoneal 
administration to rats.  Values are presented as mean and 95% confidence interval.      
 
 
3.2.2. Histopathology 
 
 All euthanized rats were killed by administration of CO2, followed by bilateral stab 
incisions of the thoracic wall. This euthanasia method created gross and histologic artifacts 
including thoracic cavity hemorrhage, pulmonary hemorrhage, hemorrhage/draining hemorrhage 
in thoracic lymph nodes, and diffuse perivascular and interstitial edema. These artifacts were 
observed in all euthanized rats to some extent, both nonsurvivors and survivors. However, some 
nonsurvivor rats had lung pathology not observed in survivors.  
 Generally speaking, for most tissues, a time lapse of 24 hours or more after tissue injury 
or death is required before microscopic changes become visible with HE staining; not 
surprisingly, in nonsurvivors that survived less than four hours (early nonsurvivors), histologic 
evidence of tissue injury or necrosis was not seen or was rarely observed. Late nonsurvivors (rats 
that survived over 20 hours PE) developed lesions not seen in early nonsurvivors. Early necrosis 
and other tissue changes were seen in several tissues in long lived nonsurvivors, and are 
discussed below. 
 
3.2.2.1  Preparation 1: 50:50 mixture of PLTX and 42-OH PLTX from Hawaiian P. tuberculosa 
 
 All 40 rats were submitted for histopathologic examination.  Twenty-two rats did not 
survive until end of study (nonsurvivors). Twenty rats were euthanized in extremis within three 
hours PE. One rat was found dead approximately 22 hours PE; one rat was found dead 
approximately 44 hours PE. The remaining 18 rats survived until end of study (survivors) and 
were euthanized as described above. 
 Five rats that survived from 1.6 hr post-exposure (PE) up to 44.3 hr PE had fibrin in the 
alveolar lumina of the lungs. Two long lived nonsurvivor rats (44 hr and 22 hr) also had 
increased numbers of alveolar macrophages often with foamy cytoplasmic material (edema or 
surfactant), or rarely with phagocytized erythrocytes (hemorrhage). One rat also had a focal 
pulmonary intravascular fibrin thrombus.  
 Hemorrhagic lesions in the structures of the head were seen in some nonsurvivors; 
similar lesions were not observed in any survivor rats. Four nonsurvivor rats had either bilateral 
or unilateral hemorrhage in the middle ear. Middle ear hemorrhage was observed subjacent to 
and elevating the epithelial lining of the tympanic cavity. Additionally, one rat had bilaterally 
symmetrical submucosal hemorrhage in the nasal cavity.  
Most (13/22) nonsurvivor rats had acute mild to marked and diffuse draining hemorrhage 
in the mandibular lymph nodes, suggesting hemorrhage and or venous impairment to structures 
of the head. No survivors had draining hemorrhage in the mandibular lymph nodes.  
 The 22 and 44 hr nonsurvivor rats were both found dead and in addition to pulmonary 
fibrin and hemorrhage, both rats had lesions in other tissues that were not seen in other 
nonsurvivors. In the liver, both had mild, multifocal, coagulative necrosis of centrilobular 
hepatocytes.  Centrilobular veins in these rats occasionally contained intravascular fibrin or 
fibrin thrombi. These two rats also had interstitial edema of the pancreas and inflammation and 
fibrin in the mesenteric fibroadipose tissue.  The 44 hour nonsurvivor rat had additional 
histologic findings of diffuse thymic cortical depletion with lymphocyte necrosis/apoptosis; 
swelling and degeneration of ducts and acinar cells of the salivary and Harderian glands, as well 
as lymphoid depletion of the spleen. Only one nonsurvivor had notable renal histopathology 
consisting of mild, multifocal renal tubular epithelial degeneration and scattered individual cell 
necrosis; some renal tubular changes in this rat were interpreted as post mortem autolysis. Three 
survivor rats had multifocal minimal (affecting less than 10% of tissue) regeneration of renal 
tubules, implying recent tubular injury and repair.  
 One rat that was found dead had marked bilateral adrenocortical hemorrhage, interpreted 
as a toxin induced lesion and/or associated with shock. One survivor rat had a focal infarction of 
the adrenal cortex, the only rat with an adrenal lesion other than hemorrhage. 
 Several survivors had evidence of peritonitis manifest by diffuse to focal inflammation of 
the splenic (11/18) and/or hepatic (7/18) capsule and/or the serosa of the stomach or intestines 
(4/18), which is attributed to IP injection of a toxic or irritant substance.  
  
   
 
3.2.2.2  Preparation 2: 42-OH -PLTX from Hawaiian P. toxica  
 In this study, 31/40 rats were submitted for histopathologic examination.  Fifteen rats did 
not survive until end of study (nonsurvivors).  Nine of these nonsurvivor rats were euthanized in 
extremis within four hours PE.  One rat was euthanized 28 hours PE.  The remaining five 
nonsurvivors were found dead from 23.6 to 28.3 hours PE.  The remaining rats (25/40) survived 
until end of study (survivors) and were euthanized as described above.  Sixteen survivors were 
submitted for histology. 
 Fibrin, in conjunction with hemorrhage, was observed in the lungs of 4/5 nonsurvivor rats 
that were found dead (not euthanized). In euthanized rats the extent of pulmonary hemorrhage 
caused by euthanasia versus PLTX could not be evaluated accurately due to artefactual changes.  
All late nonsurvivors (6/6) had early/acute coagulative necrosis of hepatocytes in the liver. The 
distribution was multifocal and random, but typically near centrilobular blood vessels. This 
lesion was not observed in early nonsurvivors or survivors.  Five of 6 late nonsurvivors had renal 
tubular epithelial degeneration often with necrosis and proteinosis.  This lesion was not observed 
in early nonsurvivors or survivors.  
Four nonsurvivor rats had either bilateral or unilateral hemorrhage in the middle ear. Middle ear 
hemorrhage was observed subjacent to and elevating the epithelial lining of the tympanic cavity. 
Two survivors had large mature fibrin thrombi in the same location of the middle ear interpreted 
as challenge related hemorrhage with progression to mature thrombi by week’s end. Four late 
nonsurvivors had acute unilateral infarction and necrosis of the adrenal gland, and one had acute 
adrenocortical hemorrhage. This lesion was not observed in early nonsurvivors or survivors.  
All late nonsurvivors (6/6) had lymphocyte necrosis and lymphoid depletion in the thymic 
cortex, lymph node(s) and/or spleen. This lesion was not observed in early nonsurvivors or 
survivors. Six nonsurvivors and most survivors had evidence of peritonitis manifest by diffuse to 
focal inflammation of the splenic and/or hepatic capsules and/or the serosa of the stomach or 
intestines.  
 An interesting finding in 5/15 nonsurvivor rats in this experiment was acute necrosis of 
salivary gland epithelium, most often of the parotid gland, but also in the submandibular and/or 
sublingual gland.  Several survivors (9/16) had evidence of regeneration of salivary epithelium 
indicating recent injury to the gland(s).  In nonsurvivors for which multiple lymph nodes were 
examined, most had evidence of hemorrhage and/or draining hemorrhage, especially in thoracic 
lymph nodes.  
   
 
3.2.2.3  PLTX from P. tuberculosa (Wako Standard)  
 In this study, 31 rats were submitted for histopathologic examination.  Fifteen rats did not 
survive until end of study (nonsurvivors).  Seven of these nonsurvivors were euthanized in 
extremis within four hours PE.  Five rats were euthanized approximately 22 hours PE.  The 
remaining 3 nonsurvivors were found dead at 3.6 hours, 3.7 hours, and 46.1 hours PE.  The 
remaining rats (25) survived until end of study (survivors) and were euthanized as described 
above.  Sixteen survivors were submitted for histology. 
 Three of 6 late nonsurvivor rats that were euthanized and one that was found dead had 
fibrin in the alveolar lumina, as well as pulmonary hemorrhage and edema. Three late 
nonsurvivors had histologic lesions consistent with early hepatocyte necrosis.  One of these late 
nonsurvivor rats was found dead at 46 hours PE, and this rat had distinct and extensive areas of 
coagulative necrosis in the liver. Two survivors had vacuolar degeneration of hepatocytes 
consistent with sublethal hepatocyte injury.   All six late nonsurvivors had some renal tubular 
epithelial degeneration and scattered individual cell necrosis in the cortices of the kidneys. These 
lesions were minimal to mild, affecting less than 10% of the cortical tubules. Significant 
proteinosis (proteinaceous fluid filling tubules, indicating inadequate glomerular and epithelial 
function) such as that seen in some rats in previous experiments, was not observed in 
nonsurvivors or survivors in this experiment.  
 
One late nonsurvivor had acute unilateral infarction of the adrenal gland cortex, and three 
late nonsurvivors had adrenal gland hemorrhage. This lesion was not observed in early 
nonsurvivors or survivors.  All (6/6) late nonsurvivors had lymphocyte necrosis in the thymic 
cortex, lymph node(s) and/or spleen. This lesion was not observed in early nonsurvivors or 
survivors.  Two nonsurvivors and 9/16 survivors had evidence of peritonitis manifest by 
diffuse to focal inflammation of the splenic and/or hepatic capsule and/or the serosa of the 
stomach or intestines.  Five nonsurvivors and two survivors had focally extensive, multifocal, or 
scattered individual cardiomyocytes with acute degeneration characterized by hypereosinophilic 
cytoplasm indicating that the cell was in a state of hypercontraction at the time it was fixed in 
formalin.  
 As with 42-OH-palytoxin, several (5/6) late nonsurvivors had acute necrosis of salivary 
gland epithelium, most often of the parotid gland, but also in the submandibular and/or 
sublingual gland. Two survivors had evidence of regeneration of salivary epithelium indicating 
recent injury to the gland(s). In the two previous experiments using PLTX and the 50:50 mix, 
many rats had hemorrhage in the middle ear. In this experiment, hemorrhage in the middle ear 
was not observed in any of the 31 rats examined histologically.   
 
3.2.2.4  Preparation 4: OVTXs from strain NIES-3351 O. ovata from Japan 
 
  In this study, 27 rats were submitted for histopathologic examination.  Nine rats did not 
survive until end of study (nonsurvivors). Seven of these nonsurvivor rats were euthanized in 
extremis within four hours PE; one was found dead at 3.8 hours PE.  One rat was euthanized at 
23.3 hours PE.  The remaining rats (31) survived until end of study (survivors) and were 
euthanized as described above.  Eighteen survivors were submitted for histology. 
 Few rats in this experiment had lesions considered relevant to toxin exposure. The lack of 
histologic lesions in most early nonsurvivor rats is due to the short interval from exposure to 
death, which was less than 4 hours for 8/9 nonsurvivors.  The single nonsurvivor that survived 
>20 hr did have lesions in several organs/tissues similar to those seen in previous IP experiments 
including: hemorrhage and fibrin in alveolar lumina of the lungs; infarction of the adrenal gland; 
acute lymphocyte necrosis in the thymus and spleen; necrosis and degeneration of acinar cells in 
submandibular and parotid salivary glands. Six nonsurvivors had acute degeneration of 
myocardiocytes multifocally within the heart; two survivors had similar findings that were 
interpreted as artifactual change unrelated to any effects of palytoxin.    
Nine of 18 survivors had inflammation of the mesentery, splenic and/or hepatic capsules. Four 
survivors had some slight increased incidence of hypercontracted cardiomyocytes. Three 
survivors had infarction/necrosis of one or both adrenal glands. One rat had extensive necrosis of 
the parotid salivary gland. One survivor rat, in addition to some degenerative changes in  the 
myocardium, had mild mononuclear inflammation of cardiac muscle in the right ventricle in 
areas of degenerative . 
 
3.2.1.5  General summary of IP exposure for all toxins 
 
 PLTX congeners administered to rats by IP injection caused histologic lesions in several 
tissues. In this series of experiments most nonsurvivor rats died or were euthanized within a few 
hours (< 4), before histologically detectable tissue changes could develop. However, in those that 
survived for 20 hours or longer, toxin induced tissue changes were observed. The most 
consistently affected organs in nonsurvivor rats were the lungs, liver, salivary glands, adrenal 
glands, and kidneys. Common nonspecific findings in many rats included lymphoid necrosis and 
draining hemorrhage. Hypercontraction of cardiomyocytes was observed in a number of rats that 
did not survive challenge, as well as some survivor rats. Acute cardiomyocyte degeneration due 
to hypercontraction can be a common background lesion and was observed in nonsurvivors, 
survivors and negative control rats from this series of experiments. However, it was observed 
that a few exposed rats that survived until end of study had myocardial inflammation and 
degenerative changes suggesting that, in addition to damage to the tissues listed above, these 
toxins also cause injury to cardiac muscle. Subsequent experiments, described below, support 
this conclusion. 
 Histologic findings in some organs differed somewhat among the different toxins. PLTX 
and 42-OH-PLTX caused distinct renal lesions in nonsurvivors including tubular degeneration, 
necrosis and proteinosis, not seen with ovatoxin-a or the 50:50 mix. For the 50:50 mix, this could 
reflect the steep dose response curves seen in the lethality studies. Some nonsurvivor rats 
challenged with the 50:50 mix and 42-OH-PLTX developed acute hemorrhage in the middle ear, 
and some survivors had organized thrombi in the middle ear indicating recent hemorrhage. 
 In summary, the IP exposures indicated that the 4 toxin preparations tested were all 
similar in potency, and the physiological effects, including toxicity to the heart, lungs, kidneys, 
and lymph nodes, were consistent with previous literature reports (Del Favero, et al, 2013; Ito 
and Yasumoto, 2009). 
 
 
3.3 Aerosol exposure studies 
 
3.3.1 Lethality 
 
The LD50 values calculated from the aerosol experiments ranged from 0.031 – 0.063   
ug/kg (Table 3).  These values are consistent with the extremely high aerosol potency predicted 
from the intoxication of beachgoers in Italy (Ciminiello, et al. 2006), as well as multiple 
incidences of exposure to marine aquarists.  As discussed above, these doses are estimates, based 
upon extrapolation of known doses.  This was necessary, as our current immunoassays are not 
sufficiently sensitive to quantitate the small amount of PLTX in the diluted AGI samples 
captured during the exposure process.  As observed with the IP data, there seemed to be little if 
any difference in potency among the toxin preparations. 
 
 
Toxin Prep                            Source                                                     LD50 (ug/kg) 
 
50:50 mix   Hawaiian P. tuberculosa    0.063 (0.053 – 0.078) 
42-OH-PLTX  Hawaiian P. toxica      0.045 (0.037 – 0.055) 
PLTX   Japanese P. tuberculosa   0.041 (0.032 – 0.052) 
Ovatoxin-a  Ostreopsis ovata culture   0.031 (0.025 – 0.039) 
 
Table 3.  Calculated LD50 values of different PLTX preparations after aerosol 
administration to rats.  Values are presented as mean and 95% confidence interval.      
 
 
 
 
3.3.2 Serial sacrifice studies  
 
Groups of female Fischer 344 rats were administered an estimated aerosol dose of 0.05 
µg/kg of each toxin preparation.  Sub-groups of rats were then euthanized and necropsied at 0, 
12, 24 and 36 hours post-exposure (PE).  
 
 
3.3.2.1 Gross necropsy results 
 
Gross lesions in rats exposed to aerosolized toxins were similar for all four toxin 
preparations.  Gross lesions, when present, were mostly confined to the lungs and liver, and 
consisted of pulmonary congestion, lobe consolidation, and/or areas of hemorrhage, and 
hepatic congestion that occasionally had a lobular pattern.  Some rats exhibited epistaxis 
and/or red crusting around the eyelids and nares.   
 
 
3.3.2.2 Histopathology 
 
3.3.2.2.1 Preparation 1: 50:50 mixture of PLTX and 42-OH PLTX from Hawaiian P.  
tuberculosa   
 
In this experiment, 15 rats were exposed. Lesions resulting from this exposure are 
summarized in Table 4 below. There were no histologic lesions attributed to toxin exposure in rats 
euthanized immediately after aerosol exposure at T = 0 hr.       
At 12 hr PE, 3/4 rats had mild or moderate degeneration and necrosis of the nasal epithelium 
with accumulation of fibrin, edema and neutrophilic inflammation, and 2/4 rats in this group had 
degeneration/necrosis of the tracheal epithelium.  In the lungs, all 4 rats had moderate 
perivascular and alveolar fibrin and/or edema, degeneration and necrosis of the epithelium lining 
the bronchioles with infiltration of neutrophils and macrophages, and an inflammatory infiltrate in 
the alveolar spaces.  In addition to the lesions in the upper and lower respiratory tracts, all rats had 
moderate (affecting around 50% of examined tissue) necrosis and/or apoptosis of lymphocytes 
(lymphocytolysis) in the thymus, the spleen, and/or one or more lymph nodes in each rat in this 
group.  Other findings attributed to toxin exposure included degeneration/necrosis of renal distal 
convoluted tubules (4/4, 100%), ductal degeneration/necrosis in the submandibular salivary gland 
(2/4, 50%), acinar degeneration/necrosis in the parotid salivary gland (1/4, 25%), minimal 
degeneration of adrenal gland cortical cells (1/4, 25%), necrotic/apoptotic cellular debris in the 
small intestine (1/4, 25%) and hemorrhage at the adrenal gland corticomedullary junction (1/4, 
25%).   
At 24 hr PE, all rats had degeneration and necrosis of the nasal and tracheal epithelium 
with inflammation.  In the lungs, all rats had similar but more severe perivascular and alveolar 
fibrin and edema, degeneration and necrosis of the bronchiolar epithelium, airway and alveolar 
neutrophils and macrophages. 
Other lesions that were similar between the 12 and 24 hr groups included 
degeneration/necrosis of renal tubules (4/4), lymphocytolysis in the thymus, spleen and one or 
more lymph nodes (4/4), degeneration and necrosis of duct epithelium in the submandibular 
salivary gland (3/3), acinar degeneration/necrosis in the parotid salivary gland (4/4) and 
degeneration of adrenal gland cortical cells (3/4). 
Additional lesions first recognized at 24 hr PE that were not present in the 0 and 12 hr 
groups included degeneration and necrosis of centrilobular hepatocytes (3/4), and 
degeneration/necrosis of cardiac myocytes (4/4). 
At 36 hr PE, all rats had lesions in the nasal epithelium, trachea, lung, kidney, liver, 
thymus, spleen, parotid and submandibular salivary glands, heart, thyroid gland, adrenal gland 
and one or more lymph nodes that were described in earlier groups. The severity varied among 
the three –being more or less severe than at earlier time points.  At 36 hr, 2/3 rats in this 
experiment had minimal degeneration or necrosis of epithelial cells of the glandular stomach. 
 
(Insert Table 4 here) 
 
 
Table 4:  Results of the aerosol exposure, serial sacrifice experiment using PLTX/42-
OH PLTX (50:50 mixture) from Hawaiian P. tuberculosa. 
 
 
 
3.3.2.2.2 Preparation 2: 42-OH -PLTX from Hawaiian P. toxica 
 
In this experiment, 20 rats were exposed.  Groups of rats were to be euthanized and 
necropsied at the following time points after aerosol exposure: 0, 12, 24, and 36 hr. However, 
except for 4 rats euthanized 0 hr, all remaining rats were euthanized or found dead around 12 
hr PE. This likely resulted from dose variability in the aerosolization process between runs, 
and the steep dose response curve of these toxins in rats. Eleven of the 20 rats were submitted 
for histologic examination. A summary of the histopathology results is shown in Table 5 
below. 
Immediately after exposure, 2/4 rats had acute hemorrhage in the nasal cavity; one of these rats 
had marked, multifocal acute pulmonary hemorrhages.  The relationship of these findings to palytoxin 
is uncertain, as no other rats from other experiments at time point 1had similar lesions.  These 
observations may be related to toxin exposure, or may be related to the aerosolization procedure or 
euthanasia.  No other histologic lesions related to aerosol exposure or suggestive of toxin exposure were 
observed in rats at time 0. 
 At 12 hr PE, all rats had nasal cavity epithelial necrosis and degeneration, and abundant 
proteinaceous luminal fluid, often with hemorrhage and neutrophilic inflammation.  All rats at 
this time point had lung injury manifest as  fibrin exudation into alveolar lumina immediately 
surrounding larger airways, interstitial and alveolar edema, increased alveolar macrophages and 
the a mild neutrophilic influx into alveoli.   Additional findings in the lungs included necrosis 
of bronchial and bronchiolar airway respiratory epithelium and alveolar septa with replacement 
by necrotic debris, neutrophils, many macrophages, fibrin, edema and hemorrhage. Marked 
congestion of the centrilobular zone of the liver was observed in most rats, and 3/7 rats had mild 
vacuolar degeneration of centrilobular hepatocytes.  Histologic changes of necrosis (pyknosis, 
hypereosinophilia, loss of differential staining) were not observed in the liver of rats in this 
experiment. Post-exposure manifestations of toxin exposure in lymphoid tissues included mild 
to marked lymphocyte necrosis in the thymic cortex, and in the spleen and/or lymph nodes, 
mild to minimal depletion of germinal centers with scattered lymphocytolysis and prominent 
tingible body macrophages.  Early mild/minimal degeneration of cardiomyocytes in the right 
ventricle was observed in 4/7 rats, and scattered necrosis of individual cells was observed in 1 
rat.  Inflammation was not observed in the heart any rats.  In the kidneys, degeneration and rare 
necrosis of distal cortical tubular epithelium was seen in 6/7 rats.  Histologic changes in the 
kidneys of affected rats were minimal to mild at best, and included cytoplasmic swelling and 
vacuolation, occasional nuclear pyknosis, and detachment from the basement membrane.  In the 
salivary glands, primarily the submandibular glands, 6/7 rats had multifocal mild degeneration 
and necrosis of duct epithelium.   
 
 
 
(Insert Table 5 here) 
 
Table 5:  Results of the aerosol exposure, serial sacrifice experiment using 42-OH 
PLTX from Hawaiian P. toxica 
 
 
 
3.3.2.2.3 Preparation 3: PLTX from P. tuberculosa (Wako Standard)  
Fifteen rats were exposed in this experiment.  Groups of rats were euthanized and necropsied at 
0, 12, 24, and 36 hr.  Results are summarized in Table 6 below. No rats euthanized immediately after 
aerosolization had histologic lesions suggestive of toxin exposure. 
At 12 hr PE, all rats had histologic lesions in the lungs.  The primary lesions included 
necrosis of large airway respiratory epithelium, fibrin exudation into alveolar lumina in areas 
surrounding large airways (secondary bronchi, bronchioles), increased alveolar macrophages, 
neutrophilic inflammation, and edema.  Lung lesions were moderate to marked in severity, 
affecting 50-75% of the lung area.  In 3/3 rats (the head was not examined for rat 2-2) mild or 
moderate degeneration and necrosis of the nasal epithelium with some neutrophilic inflammation 
was observed, and 3/4 rats had necrosis, degeneration and/or loss of tracheal respiratory 
epithelium.  Other findings at 12 hr PE included marked congestion of centrilobular zone of the 
liver in all rats without significant histologic changes in hepatocytes.  All rats had some minimal 
to mild lymphocyte necrosis and/or apoptosis of lymphocytes (lymphocytolysis) and/or depletion 
in one or more lymphoid tissues examined (thymus, spleen, mesenteric and/or mandibular lymph 
node).  In addition, 3/4 rats had early mild/minimal degeneration and acute necrosis of 
cardiomyocytes in the right ventricle and/or right papillary muscle, characterized by cytoplasmic 
pallor, swelling, or hypereosinophilia, and nuclear pyknosis with/without cytoplasmic mineral 
precipitation.  Additional findings in one or more rats were degeneration/necrosis of renal tubular 
epithelium (3/4), degeneration/necrosis of duct epithelium in the submandibular salivary gland 
(3/4), and one rat (2-3) with a focal area of acute myocyte necrosis with mixed cellular 
inflammation in skeletal muscle of the rear limb.   
 At 24 hr PE, all rats had lesions in the lungs, nasal cavity, trachea, liver, heart, lymphoid 
tissues, kidneys and salivary glands similar to those seen at 12 hr PE but with generally greater 
severity. In the lungs, fibrin exudation was more extensive, alveolar septae were often necrotic 
with local hemorrhage, and inflammation was more intense with more neutrophils, including 
degenerative neutrophils in areas of necrosis (suppurative inflammation).  In the heart, the right 
ventricular myocardium and papillary muscle were affected and infiltrates of low numbers of 
histiocytes, lymphocytes and few neutrophils were observed in areas of cardiomyocyte 
injury/necrosis.  Right myocardial interstitial edema was seen in 1/4 rats.  Coagulative necrosis of 
centrilobular hepatocytes was observed in 3/4 rats; the fourth rat had hypereosinophilic changes of 
centrilobular hepatocytes interpreted as early/peracute necrosis.  Marked to severe centrilobular 
congestion was seen in all rats at this time point.  Other findings at 24 hr PE included 
degeneration/necrosis of renal tubules (4/4), lymphoid depletion/necrosis in the thymus and one or 
more lymph nodes (4/4), duct epithelial degeneration and necrosis in the submandibular salivary 
gland (4/4).   
 At 36 hr PE, all rats had lesions in the lungs, nasal epithelium, tracheal epithelium (2/2 
examined), liver, kidney tubules, submandibular salivary glands, heart, and lymphoid tissue that 
were described in the 12 and 24 hr groups. The severity in general, was worse than that seen in 
rats from earlier time points. One rat from this time point had acute unilateral subepithelial 
hemorrhage in the middle ear cavity. 
 
(Insert Table 6 here) 
 
Table 6:  Results of the aerosol exposure, serial sacrifice experiment using PLTX 
from P. tuberculosa (Waco standard) 
 
 
3.3.2.2.3 Preparation 4: OVTXs isolated from strain NIES-3351 O. ovata from Japan 
In this experiment, 20 rats were exposed.  Groups of rats were then euthanized and 
necropsied at the following time points after aerosol exposure: 0, 12, 24, 36, and 48 hr. One 
rat (1-1) died in the exposure tube before toxin exposure and was, in essence, a negative 
control animal.  As opposed to serial sacrifice experiments with the other toxin preparations, 
in which all rats died/were euthanized by 36 hr PE, 4 rats from this experiment survived to 48 
hr PE.  Again, this could result from natural dose variability in the aerosolization procedure.  
Results are summarized in Table 7 below. 
Immediately PE, no rats had histologic lesions suggestive of toxin exposure. Histology in the 
three exposed rats was similar to that seen in the single rat (1-1) that died prior to exposure. 
At 12 hr PE, all rats had histologic lesions suggestive of toxin exposure in the lungs.  The 
primary lesions were small amounts of fibrin in alveolar lumina, neutrophilic inflammation in 
alveolar lumina and interstitial spaces (e.g. perivascular adventitia), increased alveolar 
macrophages, neutrophilic exudate in bronchi/bronchioles and necrosis of epithelium, 
perivascular and interstitial edema.  Necrosis of alveoli and/or alveolar pneumocytes was present 
but was rare.  In the nasal cavity, 3/4 rats had increased luminal proteinaceous fluid (mucin) and 
one rat had mild respiratory epithelial degeneration with a luminal neutrophilic exudate.  Marked 
congestion of the centrilobular zone of the liver was observed in 3/4 rats without significant 
histologic changes seen in hepatocytes; one rat had diffuse hepatic congestion.  All rats had some 
minimal to mild lymphocyte necrosis and/or apoptosis of lymphocytes (lymphocytolysis) and/or 
mild/minimal depletion in one or more examined lymphoid tissues (thymus, mesenteric and/or 
mandibular lymph node).  In 3/4 rats, early mild/minimal degeneration and acute necrosis of 
cardiomyocytes in the right ventricle and/or right papillary muscle was observed.  Histologic 
lesions in the heart were characterized by cytoplasmic hypereosinophilia and nuclear pyknosis 
with occasional cytoplasmic mineral precipitation.  Other findings attributed to toxin exposure 
included duct epithelial degeneration/necrosis in the submandibular salivary gland (2/4). 
  At 24 hr PE, all rats had lesions in the lungs, nasal cavity, liver, right heart, lymphoid 
tissues, and salivary glands.  Histologic features were significantly more severe than at 12 hr PE 
in most tissues.  Differences in key tissues from the 12 hr time point included more extensive 
pulmonary fibrin exudation affecting around 50% of the lung in all rats, often diffuse (marked to 
severe) necrosis of lining epithelium in large and medium sized airways, necrosis of alveolar 
septae with local hemorrhage, and intense neutrophilic inflammation, including degenerative 
neutrophils in areas of necrosis (suppurative inflammation), and widespread marked pulmonary 
and interstitial edema.  In the nasal cavity, especially the caudal nasal cavity, there was 
multifocal to focally extensive necrosis and degeneration of epithelium, abundant luminal fluid 
and exudate.  In 3/4 rats, tracheal luminal necrotic cellular exudate and neutrophils were 
observed.  In the liver, centrilobular congestion was seen in all rats but additionally at this time 
point vacuolar degeneration of centrilobular hepatocytes was seen in 2/4 rats and early histologic 
changes suggestive of necrosis were also occasionally observed in these same two rats.  In the 
right ventricular myocardium and papillary muscle, foci of degeneration and necrosis were 
observed, often with infiltrates of low numbers of neutrophils and histiocytes.  At 24 hr PE a 
high percentage (50-75% estimated) of lymphocytes in the thymic cortex were necrotic.  
  At 36 hr PE, all rats had lesions in the lungs, nasal epithelium, liver, heart, salivary glands, 
and lymphoid tissue that were described in the 12 and 24 hr groups, with exceptions discussed 
below. The severity of tissue injury and inflammation in the lungs and liver was, in general, 
worse than that seen in rats from earlier time points.  In the liver, 2/4 rats had diffuse severe 
necrosis of centrilobular hepatocytes not seen at/before 24 hr. Also, 1/4 rats had hepatocyte 
degeneration and early necrosis similar to the 24 hr group, and one rat had minimal/no liver 
lesions other than centrilobular congestion.  All four rats had diffuse severe necrosis of 
lymphocytes in the thymic cortex.  Two rats had mild lesions in the kidneys consisting of 
degeneration (swelling) of cortical tubular epithelium and one of these rats had individual 
necrosis of epithelial cells and mild proteinosis.  All four rats at 36 hr had degeneration of 
salivary gland duct epithelium, but 2/4 had necrosis of acinar cells in the parotid salivary glands 
as well.  One rat had mild focal skeletal muscle degeneration/necrosis in the hind limb. 
 At 48 hr PE, once again, all rats had pulmonary fibrin, inflammation, necrosis and nasal 
cavity epithelial degeneration/necrosis.  One rat had marked centrilobular hepatocyte necrosis, 
3/4 had centrilobular hepatocyte degeneration, and 4/4 had centrilobular hepatic congestion.  All 
rats had severe depletion of the thymic cortex, and 2/4 had mild degeneration of salivary gland 
duct epithelium.  Lung lesions were most severe in the 48 hr rats, in particular the intensity of 
inflammation and widespread tissue destruction.  Lung lesions often involved over 90% of 
individual lung lobes.  Fibrin deposits showed histologic evidence of polymerization 
(maturation), and reparative efforts such as respiratory epithelial hyperplasia in airways and type 
2 pneumocyte hyperplasia in alveoli.  At this time point, other tissues showed recovery from 
acute injury (e.g. salivary glands) and reparative efforts such as goblet cell hyperplasia in nasal 
cavity epithelium, in addition to those noted in the lungs. 
 
(Insert Table 7 here) 
 
Table 7:  Results of the aerosol exposure, serial sacrifice experiment using ovatoxins 
purified from strain NIES-3351 O. ovata from Japan 
 
 
 
4. Discussion of Histopathologic Observations 
Histopathologic findings in rat serial sacrifice experiments were nearly identical using all 
four toxin preparations when delivered by aerosol.  The progression of pathologic lesions in 
serial sacrifice experiments followed the same pattern of dissemination and worsening severity 
over time as seen in the LD50 aerosol experiments and, with the exception of lesions in the 
lungs, the IP injection experiments.   
 
  
All aerosolized PLTX preparations caused nasal cavity epithelial degeneration and 
necrosis. In the nasal cavity, respiratory epithelium showed degeneration with scattered 
necrosis and sloughing at 12 hr which progressed to focally extensive areas of degeneration 
and necrosis with a neutrophilic infiltrate and luminal exudate composed of neutrophils and 
proteinaceous fluid by 24 to 36 hr.  Some rats had active nasal cavity epithelial degeneration 
and necrosis at 48 hr, but also recovery/regeneration of injured lining epithelium and an 
increase in mucin producing goblet cells. 
  
The major effects of aerosolized PLTX on the lungs was fibrin exudation and tissue 
necrosis and were first evident at 12 hr PE.  The pathologic effects of PLTXs on the trachea 
and lungs were apparent in all rats at 12 hr PE and were initially characterized by degeneration 
and necrosis of respiratory epithelium in the trachea, bronchi and bronchioles, with epithelial 
sloughing and variable numbers of neutrophils in the airway lumina.  The first evidence of 
injury to lung parenchyma (i.e. alveoli) was seen at 12 hr and manifest as fibrin exudation into 
alveolar lumina immediately surrounding larger airways, respiratory epithelial necrosis in large 
airways, occasional alveolar septal necrosis, interstitial and alveolar edema, increased alveolar 
macrophages and the beginnings of a neutrophilic influx into alveoli and interstitial spaces.  By 
24 to 48 hr, fibrin exudation was widespread to areas distant from peribronchial or bronchiolar, 
perivascular, and other interstitial spaces.  Consistent findings at 24 hr and later included 
necrosis and loss of alveolar septa and transmural necrosis of large/medium airways, with 
replacement by necrotic debris, viable and degenerate neutrophils (suppurative inflammation), 
many macrophages, fibrin, edema and hemorrhage.   With the ovatoxins, where four rats 
survived to 48 hr, most rats had transmural necrosis of large and medium airways and 
polymerized (mature) fibrin in alveoli.  These rats, similar to long-lived survivors in previous 
LD50 experiments, had lesions of tissue repair in the lungs to include type 2 pneumocyte 
hyperplasia and, in those bronchioles and bronchi less affected by necrosis, hyperplasia of 
respiratory epithelium.  
 
 The different PLTXs specifically affected the centrilobular zone of the liver.  At 12 hr 
PE, the majority of rats had significant congestion of the centrilobular zone of the liver, 
interpreted as an early manifestation of hepatocyte injury to this zone of the liver.  At 24 hr PE, 
degeneration of hepatocytes characterized by cytoplasmic swelling and vacuolation specifically 
in the centrilobular zone was observed in a high number of rats, and frequently histologic 
changes consistent with early necrosis, including loss of differential staining and 
hypereosinophilic cytoplasm, was seen.  By 36 hr many rats went on to develop diffuse 
centrilobular hepatocyte necrosis with centrilobular congestion and some hemorrhage, and 
degeneration of adjacent surviving hepatocytes.  Mild neutrophilic inflammation in areas of 
hepatocyte necrosis was seen in areas of liver necrosis in one of the rats that survived to 48 hr.  
 
 The different PLTXs all caused lymphoid tissue necrosis and depletion, especially in the 
thymus.  Post-exposure manifestations of toxin exposure in lymphoid tissue (thymus, spleen 
and/or lymph nodes) at 12 hr were composed of minimal to mild thinning (depletion) of 
germinal centers and/or the thymic cortex, with scattered lymphocytolysis and prominent 
tingible body macrophages.  At 24 hr, effects on lymphoid tissue were seen primarily in the 
thymic cortex, with diffuse apoptosis/necrosis of lymphocytes.  At 36-48 hr, all rats had 
diffuse depletion of the thymic cortex with very little remnant necrotic cellular debris at 48 hr. 
 
 The most commonly and/or exclusively affected areas of the heart were the right 
ventricle and/or right papillary muscles.  Some mild myocardial lesions were observed in rats 
at 12 hr, consisting of scattered foci of acute degeneration with cytoplasmic swelling or 
vacuoles, or necrosis, characterized by nuclear pyknosis, cytoplasmic hypereosinophilia 
and/or fragmentation, and often with cytoplasmic mineral.  At 24 hr, multifocal to focally 
extensive areas of myocardial degeneration and necrosis and interstitial edema were observed 
in the right ventricle/papillary muscle, and by 36 hr and later, low numbers of neutrophils and 
histiocytes were observed infiltrating areas of cardiomyocyte injury and loss.  In the IP 
experiments, equivocal changes to cardiac muscle were observed and consisted of acute 
degeneration without hyaline change, overt necrosis or inflammation. However, in aerosol 
serial sacrifice experiments, and LD50 aerosol experiments, definitive histologic changes to 
cardiac myocytes were observed fairly consistently at 12 hr and were followed at later time 
points in many rats by distinct lesions of myocardial necrosis and inflammation, thus 
supporting the conclusion that IP administration of PLTX also  affects cardiac muscle. 
In the kidneys, degeneration and scattered necrosis of proximal cortical tubular 
epithelium was seen in rats from 12 -36 hr.  Histologic changes in most affected rats were 
minimal to mild at best, and included cytoplasmic swelling and vacuolation, occasional 
nuclear pyknosis, and detachment from the basement membrane.   
 In the salivary glands, primarily the submandibular glands, widespread degeneration 
and necrosis of duct epithelium was seen, as well as swelling of acinar cells.  Foci of acinar 
cell necrosis in the serial sacrifice experiments were rare, but a higher incidence of salivary 
gland necrosis, especially the parotid gland, was seen in several rats in IP experiments using 
42-OH-PLTX, PLTX, and ovatoxins.  Survivors of the IP experiments often had regeneration 
of salivary gland acini and duct epithelium. 
Lesions that were observed in a number of rats in the IP experiments that were rarely or 
not seen in the serial sacrifice aerosol experiments included unilateral or bilateral subepithelial 
hemorrhage in the middle ear (total of ten rats using the 50:50 mix and 42-OH-PLTX), and 
adrenal gland necrosis, infarction and/or hemorrhage, seen in a total of 10 rats from the 42-
OH-PLTX, PLTX and ovatoxin preparations.   
In our experiments, lesions in the gastrointestinal tract and lesions of skeletal muscle 
degeneration and necrosis were rarely seen, regardless of route of administration, and were 
mild to minimal in the few affected animals.   
 
    
5. Conclusions 
 
 Palytoxin derived from Japanese Palythoa tuberculosa, and the congeners 42-OH-PLTX 
(from Hawaiian P. toxica) and ovatoxin-a (isolated from a Japanese strain of Ostreopsis ovata), 
as well as a 50:50 mix of PLTX and 42-OH-PLTX derived from Hawaiian P. tuberculosa were 
evaluated for lethality and pathophysiological effects after IP and aerosol administration to rats.  
The LD50 values derived from these experiments (1-3 µg/kg by IP, 0.03 – 0.06 µg/kg by aerosol) 
confirmed the exquisite potency of these compounds, although some differences from the 
published literature were seen.  In particular, although we saw a slight trend for ovatoxin-a to be 
slightly less potent than the other congeners, this difference was uniformly small or absent in in 
vivo and in vitro models. These results conflict with multiple published reports that ovatoxin-a is 
10-100-fold less potent in several in vitro models.  This may reflect differences inherent to in 
vivo and in vitro methods, as in vitro models typically reflect a single tissue type and thus offer a 
restricted view of the pharmacokinetics and metabolism that are significant factors in in vivo 
models.  Alternately, it may reflect differences between the ovatoxin-a typically seen in 
Mediterranean/Adriatic strains of O. ovata and the ovatoxin-a (AC) isomer produced by our 
Japanese strain. In addition, we did not observe differences in potency between the 42-OH-
PLTX produced by P. toxica (42S-hydroxy-50S-PLTX) and the 42-OH-PLTX produced by P. 
tuberculosa (42S-hydroxy-50R-palytoxin), as suggested by Ciminiello et al (2014). This again 
may reflect differences between the in vitro and in vivo systems used. 
 The pathophysiological effects of the different toxin preparations were similar in both 
routes of administration. Although some differences were noted between IP and aerosol 
administration – most notably in the lungs - these results suggest commonalities in mechanism of 
action and potency among the PLTX congeners tested here. There is little published information 
specifically pertaining to IP and aerosol effects of PLTX congeners in rats to which we can 
compare our data, and what is available is difficult to compare directly due to differences in 
experimental parameters or methodology.   However, the available literature suggests that these 
toxins affect a wide range of tissues in a variety of species when administered by multiple routes. 
Most consistently reported are effects on renal, pulmonary, cardiac, and hepatic tissues, which 
we also observed here.  In addition, we observed effects in lymphoid tissues and salivary glands, 
but little or no effects on skeletal muscle or gastrointestinal tissues. 
 These preliminary histopathology results were not designed to be an exhaustive study, 
but instead to confirm activity in our preparations and to help inform model development.  We 
believe our preparations are sufficiently characterized as to content, purity, and activity to move 
forward with our ultimate goal of evaluating aerosol toxicology in nonhuman primates. It is 
anticipated that this data will provide useful information to support the associations seen between 
PLTX/OVTX and their congeners and toxic events in humans due to presumed aerosol exposure. 
Ultimately, we will develop an animal model to support the development of medical 
countermeasures. 
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